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Abstract 
Background: The 11th revision to the WHO International Classification of Diseases (ICD-
11) identified Complex Posttraumatic Stress Disorder (CPTSD) as a new condition. There is 
a pressing need to identify effective CPTSD interventions.  Methods: We conducted a 
systematic review and meta-analysis of Randomised Controlled Trials (RCTs) of 
psychological interventions for Posttraumatic Stress Disorder (PTSD), where participants 
were likely to have clinically significant baseline levels of one or more CPTSD symptom 
clusters (affect dysregulation, negative self-concept and/or disturbed relationships). We 
searched MEDLINE, PsycINFO, EMBASE and PILOTS databases (January 2018), and 
examined study and outcome quality. Results: Fifty-one RCTs met inclusion criteria. 
Cognitive Behavioural Therapy (CBT), Exposure alone (EA), and Eye Movement 
Desensitization and Reprocessing (EMDR) were superior to usual care for PTSD symptoms, 
with effects ranging from g = -0.90 (CBT; k=27, 95% CI -1.11, -0.68; moderate quality) to g 
= -1.26 (EMDR; k=4, 95% CI -2.01, -0.51; low quality). CBT and EA each had moderate-
large or large effects on negative self-concept, but only 1 trial of EMDR reported this 
outcome. CBT, EA and EMDR each had moderate or moderate-large effects on disturbed 
relationships. Few RCTs reported affect dysregulation data. The benefits of all interventions 
were smaller when compared to non-specific interventions (e.g., befriending). Multivariate 
meta-regression suggested childhood-onset trauma was associated with a poorer outcome.  
Conclusions: The development of effective interventions for CPTSD can build upon the 
success of PTSD interventions. Further research should assess the benefits of flexibility in 
intervention selection, sequencing and delivery, based on clinical need and patient 
preferences.   
Keywords: CPTSD, psychological therapies, childhood trauma, systematic review, meta-
analysis, randomised controlled trials 
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Introduction 
 
The 11th revision to the World Health Organization’s International Classification of 
Diseases (ICD-11) (WHO, 2018) includes two distinct sibling conditions, Posttraumatic Stress 
Disorder (PTSD) (code 6B40) and Complex PTSD (CPTSD) (code 6B41), under a general 
parent category of ‘Disorders specifically associated with stress’. PTSD is comprised of three 
symptom clusters including (1) re-experiencing of the trauma in the here and now, (2) 
avoidance of traumatic reminders, and (3) a persistent sense of current threat that is manifested 
by exaggerated startle and hypervigilance. ICD-11 CPTSD includes the three PTSD clusters 
and three additional clusters that reflect ‘disturbances in self-organization’ (DSO); (1) affect 
dysregulation, (2) negative self-concept, and (3) disturbances in relationships (Maercker et al., 
2013). These disturbances are proposed to be typically associated with sustained, repeated, or 
multiple forms of traumatic exposure (e.g., genocide campaigns, childhood sexual abuse, child 
soldiering, severe domestic violence, torture, or slavery) (Karatzias et al., 2017), reflecting loss 
of emotional, psychological, and social resources under conditions of prolonged adversity 
(Cloitre et al., 2013).  
The qualitative distinction between PTSD and CPTSD symptomatology has been 
supported in different trauma samples (see Brewin et al., 2017) including those experiencing 
interpersonal violence (Cloitre et al., 2013), rape, domestic violence, traumatic bereavement 
(Elklit, Hyland, & Shevlin, 2014), survivors of institutional abuse such as that occurring within 
foster care and religious organizations (Knefel et al., 2015) and refugees (Hyland et al., 2018). 
The distinction between PTSD and CPTSD has also been confirmed in samples of young adults 
(Perkonigg et al., 2014) and children (Sachser, Keller, & Goldbeck, 2016). The second-order 
factorial structure of CPTSD in which the disorder is comprised of both PTSD and DSO has 
also been supported in previous research (e.g. Karatzias et al., 2016; Hyland et al., 2017a; 
Hyland et al., 2017b; Shevlin et al., 2017). 
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To date a number of meta-analyses and systematic reviews have investigated the 
effectiveness of PTSD treatments in general (Barrera et al, 2013; Bisson & Andrews, 2005, 
2007; Bisson et al., 2007; Bisson et al., 2013; Callahan et al 2004; DeJong & Gorey, 1996; 
Ehring et al, 2014; Pelekis & Dahl, 2005; Roberts et al, 2015; Sloan et al, 2013; Taylor & 
Harvey, 2009; Taylor & Harvey 2010; Watts et al, 2013). Overall, previous meta-analyses have 
supported the efficacy of trauma-focused psychological treatments, such as Cognitive 
Behavioural Therapy (CBT) and Eye Movement Desensitization and Reprocessing (EMDR), 
for the treatment of DSM-IV PTSD, a condition of three clusters of symptoms including re-
experience, avoidance of the traumatic reminders and hyperarousal. CBT and EMDR target 
patients’ memories of their traumatic events and the personal meanings of the trauma and 
typically include repeated in vivo and/or imaginal exposure to the trauma, reappraisal of the 
meaning of the trauma and its consequences, or some combination of these techniques (e.g. 
Bisson et al., 2013). These approaches have been identified as efficacious for a range of PTSD 
survivors, including rape victims, survivors of childhood abuse, refugees, combat veterans, and 
victims of motor vehicle accidents (Foa et al.  2009), although most existing evidence on these 
interventions concerns single adult traumas (e.g. Bisson et al., 2013). There is disagreement 
whether trauma focused treatments are optimal for more complex traumatic presentations such 
as CPTSD. For complex traumatic presentations, a phase-based model, originally proposed by 
Herman (1992), has been suggested as the preferred treatment option (Cloitre et al., 2012).  
Phased interventions address disturbances in self-organization and related problems in 
day to day functioning (e.g., improving safety, emotion regulation and social skills) first, while 
explicit exploration of the trauma (e.g., exposure) is subsequently introduced (Cloitre et al., 
2012b). The rationale for this sequencing is two-fold; firstly to increase emotional, 
psychological and social resources to improve functioning in daily life and secondly, to use 
these resources to enhance the effectiveness of trauma-focused work. Whilst there is some 
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support for this approach (e.g., Cloitre et al., 2010), it is uncertain if a stabilisation phase is 
necessary and it might lead to unhelpful delays in using more trauma-focused interventions 
(De Jongh et al., 2016). Another approach to managing complex traumatisation focuses on 
treating symptoms that are co-morbid with PTSD. Empirical investigations have generally 
demonstrated the feasibility and effectiveness of these approaches. Examples include PTSD 
with Substance Use Disorder (SUD) (Mills et al., 2012) where SUD and PTSD interventions 
are integrated and implemented relatively simultaneously and PTSD with Borderline 
Personality Disorder (BPD) (Harned, Korslund and Linehan, 2014) where ideally the BPD and 
PTSD interventions occur concurrently (but only once the patient has developed the emotional 
and behavioural control to tolerate the PTSD intervention). However, it is important to 
emphasise that CPTSD is not identical to PTSD and its co-morbidity but is rather a distinct 
disorder with a specific symptom profile.   
Considering that ICD-11 CPTSD is a new condition, it will take a substantial amount 
of time before an evidence base accumulates regarding its treatment. However, there is 
evidence on interventions that addressed at least partially the symptoms of CPTSD, including 
those of DSO.  The aim of this systematic review and meta-analysis was to synthesise the 
evidence on effectiveness of treatments for the symptoms of CPTSD and identify therapies that 
look most promising for treating the symptoms of CPTSD. To achieve this goal, we examined 
evidence from trials for PTSD where participants were also likely to have clinically significant 
levels of one or more CPTSD DSO symptom clusters at baseline, and where usable data on the 
effect of interventions on these symptoms were reported. We also aimed to explore the 
moderating effect of RCT quality, the developmental timing of traumatic exposure (childhood 
vs. adulthood), phased vs. non-phased interventions, and individual vs. group interventions on 
treatment outcome. Our ultimate goal was to create a list of research priorities to inspire future 
research in the treatment of ICD-11 CPTSD. 
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Method 
Protocol registration 
A protocol for this systematic review and meta-analysis was pre-registered 
(CRD42017055305) on February 2017. Changes to the protocol are listed in the supplement.  
 
Search strategy and study selection 
The search process was conducted in three main phases. First, MEDLINE, PsycINFO, 
EMBASE and PILOTS databases were searched for studies published from database inception 
to October 2017 using the following search terms: (“PTSD” or “posttrauma*” or 
“psychological stress*” or “combat” or “post-trauma*” or “gross stress reaction” or “stress 
disorder*” or “trauma*” or “psychological trauma”) AND (“randomised” or “randomized” or 
“randomised controlled trial” or “randomized controlled trial” or “RCT”) AND (“therapy” or 
“psychological therapy” or “psychological intervention” or “intervention” or “treatment”). The 
only limiter applied in this search was language (English only). Second, to update the search, 
the same databases were searched for studies published from database inception to January 
2018 using similar search terms: (“PTSD” or “posttrauma*” or “psychological stress*” or 
“combat” or “post-trauma*” or “gross stress reaction” or “stress disorder*” or “trauma*” or 
“psychological trauma”) AND (“randomised” or “randomized” or “RCT”) AND (“therapy” or 
“intervention” or “treatment”) . Limiters applied in this search were language (English only), 
humans, age group (adolescence, defined as between 13 and 17 years old, and adulthood, 
defined as 18 years and older), treatment and prevention, and randomised controlled trials. 
Third, the reference lists of earlier systematic reviews and meta-analyses of clinical trials for 
PTSD were screened for additional studies (Bisson et al., 2013; Bradley et al., 2005; Cusack et 
al., 2016; Ehring et al., 2014; Imel et al., 2013; Kline et al., 2018). Three independent 
investigators (AB, SR, PM) carried out the search. Any discrepancies between search results 
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were discussed and resolved with members of the research team (PHU, TK). As a final step, 
unpublished data were identified through contacting investigators and searching clinical trial 
registries (ClinicalTrials.gov and the UK Clinical Trials Gateway).  
Studies were eligible for inclusion if they were randomised controlled trials (RCTs) 
reporting the effects of an individual or group-based psychological intervention for adults 
(mean age ≥16 years) with PTSD (ICD-10 and/or DSM-III-IV criteria), if participants 
experienced at least one of the additional CPTSD criteria at baseline (affect dysregulation, 
negative self-concept and disturbances in relationships, as defined in ICD-11), and if 
participants were free from developmental or intellectual disability, neurodegenerative 
disorders and acquired and/or traumatic brain injury. Studies where participants had comorbid 
substance misuse difficulties or other mental health conditions were included, but studies where 
participants had a primary diagnosis of substance misuse disorder were excluded. Case studies, 
uncontrolled trials and crossover trials were not included. 
To establish whether participants had clinically significant levels of one or more of the 
additional CPTSD symptom clusters at baseline, any published clinical cut-offs relating to the 
CPTSD syndrome or individual CPTSD DSO symptoms were referred to in the first instance. 
If these were not available, any original validation study of the CPTSD index was referred to 
in order to try to identify relevant healthy norms; if the mean of the participants was more than 
one standard deviation (SD) away from the mean of these norms (in the direction of 
impairment), participants were considered to have clinically significant levels of the relevant 
CPTSD index. If there was no original validation study or if studies did not contain relevant 
healthy norms, studies that contained such norms was then searched for; if there were multiple 
studies, those with the largest sample sizes were prioritised. If the above clinical cut-offs or 
relevant norms could not be obtained, a decision about clinical significance was made on a 
case-by-case basis (e.g., if the participants’ mean on a CPTSD DSO symptom indicated that 
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they were closer to being intact than impaired, they were not considered to have clinically 
significant levels of the relevant CPTSD symptom).    
We defined a ‘psychological intervention’ as a talk-based intervention delivered by a 
trained therapist who adapted the treatment to patients on the basis of a therapeutic relationship 
(i.e., no delivery of a non-modifiable standard protocol, e.g., progressive muscle relaxation) 
(Benish, Imel and Wampold, 2008), and met at least two of the following four criteria: (a) a 
citation to an established school or approach to psychotherapy; (b) a description of the therapy 
that contained a reference to a psychological process (e.g., operant conditioning); (c) a 
reference to a treatment manual that was used to guide the delivery of the treatment; (d) the 
identification of active ingredients of the treatment and citations for these ingredients. Some of 
the face-to-face interventions we included did not meet these criteria (e.g., mindfulness, yoga), 
however we decided to report their effects in the interests of completeness. Online or other 
non-face-to-face interventions, even though they may meet these criteria, were excluded 
because of their different method of delivery and in an effort to reduce heterogeneity. 
We further categorized psychological interventions into four different groups; (a) CBT 
(see definition below); (b) exposure therapy alone (i.e., psychological interventions, which 
were not better defined as CBT, emphasizing exposure to the trauma memory as the principal 
active treatment component, such as PE and imaginal exposure); (c) EMDR (i.e., psychological 
interventions consistent with the manual by Shapiro, 1995); (d) other psychological 
interventions (e.g., mindfulness). As per NICE guidelines, CBT was defined as a discrete 
psychological intervention where service users: (i) establish links between thoughts, feelings 
or actions with respect to the current or past symptoms, and/or functioning; (ii) re-evaluate 
their perceptions, beliefs or reasoning in relation to the target symptoms (National 
Collaborating Centre for Mental Health, 2014). To be categorized as CBT, the intervention 
also had to focus on at least one of the following: (iii) service users monitoring their own 
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thoughts, feelings or behaviours with respect to the symptom or recurrence of symptoms; (iv) 
promotion of alternative ways of coping with the target symptom (National Collaborating 
Centre for Mental Health, 2014). Given this broad definition of CBT, psychological 
interventions which involved cognitive/imagery modification with or without exposure therapy 
were considered to be CBT in nature.   
We compared psychological intervention(s) to each other or to a control condition, 
which could be treatment as usual (TAU; also included 'waiting list control'), or TAU plus a 
non-specific therapeutic intervention (i.e. befriending, counselling).  
 
Outcomes and data extraction 
Our primary outcome was the standardised difference between groups at end of 
treatment in severity of (a) PTSD symptoms (as per ICD-11, DSM III-IV criteria) and (b)  affect 
dysregulation, negative self-concept and disturbances in relationships. These were also used to 
calculate the associated number needed to treat (NNT) for clinically significant response, based 
on different estimates of response rates in the control condition.  
Two reviewers (PHU, AB) extracted data relating to study characteristics, including 
details on participants, interventions received and outcomes assessed. Three reviewers (PM, 
AB, SR) also completed independent assessments of whether participants’ mean baseline 
scores on measures of CPTSD symptoms were within the clinical range, which were then 
discussed and approved by two other reviewers (TK, PHU). Study authors were contacted in 
every case where CPTSD-relevant outcomes appeared to have been assessed but not reported. 
To assess outcomes, we extracted means and standard deviations (SD) where possible. If SDs 
were not reported, then these were derived from standard errors, confidence intervals, p-values 
or t-values where possible, following Cochrane Handbook procedures (Higgins and Green, 
2011).  
Psychological therapies for CPTSD symptoms 
10 
 
Analysis 
We used Comprehensive Meta-Analysis software (version 3) for the meta-analyses. We 
first calculated the post-intervention standardised mean difference (Hedges’ g) and standard 
error (SE) for each individual study on each outcome (PTSD, affect dysregulation, negative 
self-concept, disturbances in relationships). Hedges’ g was selected as the effect size measure 
because it accounts for variation in sample size and sample variance (Deeks, Altman and  
Bradburn, 2001). A composite effect was also computed for each study by combining PTSD 
and any available CPTSD DSO outcome data. To do this, we computed the average Hedges’ g 
and associated SE across the outcomes. The range of measures used to assess these meant it 
was not feasible to adjust the composite estimate for the between-outcome correlation, and had 
to instead assume this was zero. When the number of participants (N) contributing data to each 
domain differed, we used the smallest N for the composite estimate. When there was sufficient 
data (at least two studies), we calculated the differences between interventions and controls on 
PTSD, affect dysregulation, negative self-concept, and disturbances in relationships 
individually, using DerSimonian and Laird (1986) random-effects meta-analyses. We then 
pooled data from studies reporting PTSD plus (a) 1, 2 or 3 CPTSD DSO outcomes, (b) 2 or 3 
CPTSD DSO outcomes, and (c) all 3 CPTSD DSO outcomes. The estimates were expressed in 
units of Hedges’ g with associated 95% confidence intervals. Between group differences in 
clinically significant change were derived from the Hedges’ g estimate and an assumed control 
event response rate (CER) using the Furukawa method (Furukawa, 1999; Furukawa and 
Leucht, 2011; http://rpsychologist.com/d3/cohend/) and presented as NNT for benefit or harm. 
Morina et al., (2014) report a CER of 44% for PTSD however because CPTSD is assumed to 
have a poorer prognosis we estimated what the NNT to benefit or harm would be if we halved 
this value to 22%. We also estimated what the NNT would be if the natural remission rate in 
the control conditions was either very high (50%) or very low (10%). Using the relative group 
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difference and a range of assumed CERs to compute NNT is the method recommended by the 
Cochrane Handbook, since this “helps users to understand the important impact that typical 
baseline risks have on the absolute benefit that they can expect” (Higgins and Green., 2011).     
The potential impact of publication bias was assessed using funnel plots, Egger’s test 
and Duval and Tweedie’s Trim-and-Fill procedure (random-effects) (Duval and Tweedie, 
2000; Egger et al., 1997), but only for analyses derived from at least 10 studies (Higgins and  
Green, 2011). Cohen’s (1988) established conventions (small = 0.2, moderate = 0.5, large = 
0.8) were used to interpret individual and meta-analytical estimates of Hedges’ g. Statistical 
significance was inferred when p-values were below 0.05, although values between 0.01 and 
0.09 were downgraded for imprecision. Heterogeneity was assessed using the I2 statistic, and 
compared with thresholds specified in the Cochrane Handbook (<40% low; 30-60% moderate; 
50-90% substantial; 75-100% considerable) (Higgins and  Green, 2011).  
 
Assessment of study and outcome quality 
Individual study quality was assessed using the Cochrane Collaboration Risk of Bias 
tool (Higgins et al., 2011) and meta-analytical estimates were assessed using the GRADE 
approach (Guyatt et al., 2008) (see supplement). The GRADE approach considers the quality 
of studies contributing to each analysis, the consistency, directness and precision of the pooled 
estimate, and the risk of publication bias. 
Cochrane risk of bias ratings were completed by two reviewers independently (PM, 
AB), and checked by a third (PHU). An overall individual study quality rating was also 
produced (see supplement for criteria). GRADE ratings were performed by one reviewer 
(PHU) and checked by two others (PM, TK). An overall GRADE assessment is provided 
alongside each outcome to inform the interpretation of these findings.  
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Moderator analyses 
We combined all studies into a single dataset to conduct a series of pre-specified 
univariate moderator analyses, and one multivariate analysis, again using Comprehensive 
Meta-Analysis software (version 3). The outcome for each meta-regression analysis was the 
post-treatment group difference in CPTSD symptom severity. For this we used, in order of 
preference, the composite estimates of differences in (1) PTSD plus the three CPTSD DSO 
symptom clusters; (2) PTSD plus two CPTSD DSO symptom clusters (3) PTSD plus one 
CPTSD DSO symptom cluster or (4) PTSD alone. 
Pre-specified univariate analyses included the relevant Cochrane Risk of Bias 
parameters (sequence generation, allocation concealment, detection bias, reporting bias, 
attrition bias), onset of trauma (childhood vs adulthood), degree to which sample met CPTSD 
criteria (i.e., whether data on PTSD plus three, two, one or no CPTSD DSO symptom clusters 
were used) and therapy format (individual vs group). There was insufficient data to support 
pre-specified analysis of phased vs non-phased interventions. We also examined the effect of 
therapy type (individual CBT, group CBT, EMDR, exposure alone, group IPT), and the effect 
of using a non-specific control condition (i.e., versus a usual care / waiting list control group). 
To ensure that all studies with 3 or more arms could be included without double-counting of 
participants, we split the sample size of any shared treatment or control arms in half for these 
comparisons, as recommended in the Cochrane Handbook (Higgins and Green, 2011), and 
revised the individual study effect sizes accordingly. To ensure power for the multivariate 
analyses, we limited this to 5 variables; study quality, therapy type, degree to which sample 
met CPTSD criteria, trauma onset, and use of a non-specific control condition.  
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Results 
Study selection 
The search returned 28,521 results, of which 28,310 were excluded on the basis of title 
or abstract (see Figure 1). Following title and abstract screening, the full texts of the remaining 
211 articles were examined. One hundred and forty one full text articles were excluded. A 
further 19 full text articles were excluded because they described studies that did not include 
clinically significant levels of one or more CPTSD DSO symptom clusters at baseline. Fifty-
one studies met full inclusion criteria and were included in the current study. Of these, 35 
studies had a CBT arm, 11 had an exposure only arm, 9 had an EMDR arm, and 9 assessed the 
effect of other interventions, including interpersonal psychotherapy (IPT), mindfulness, trauma 
management training (TMT), dialogical exposure therapy (DET), dialectical behaviour 
therapy, CBT plus emotion regulation training, and stabilisation therapy. Figure 2 provides an 
overview of studies contributing to each analysis. A table of included study characteristics and 
a table of excluded studies, with reasons for exclusion, are provided in the supplement. 
 
Insert Figure 1 
 
Insert Figure 2 
 
Quality assessment 
The results of the Cochrane risk of bias assessment are shown in the supplement and 
GRADE ratings for each meta-analytical outcome are shown below and in the far right column 
of Tables 1-4 and Table J.1 (supplement). Just over half of the included studies used appropriate 
methods to generate a random sequence to allocate participants to groups, but poor reporting 
limited our assessment of this domain. A slightly smaller proportion had a low risk of bias for 
Psychological therapies for CPTSD symptoms 
14 
 
allocation sequence concealment, but again poor reporting prevented a clear assessment of this 
domain. The majority of studies had a low risk of detection bias because assessors were 
unaware of the group that participants had been allocated to. Most also had a low risk of 
attrition bias with acceptable rates of missing post-intervention data (<25%). However, most 
had a high risk of reporting bias primarily due to a lack of a preregistered protocol. The risk of 
performance bias was unavoidably high across all studies due to the nature of the interventions, 
which precluded blinding of participants. Overall, we rated the majority of studies as high in 
methodological quality. 
 
Meta-analytical outcomes  
Cognitive behavioural therapy (CBT) (Table 1, and supplement) 
As shown in Table 1, compared to usual care, CBT had a moderate-large effect on 
disturbances in relationships (k=16, g = -0.66; 95% CI = -0.84, -0.48) and large effects on affect 
dysregulation (k=3, g = -1.42; 95% CI = -2.20, -0.65), negative self-concept (k=9, g = -0.82; 
95% CI = -1.19, -0.44) and PTSD symptoms (k=27, g = -0.90; 95% CI = -1.11, -0.68) (all 
moderate quality evidence), with the NNT varying from 2 (affect dysregulation assuming CER 
of 22%) to 6 (disturbances in relationships assuming CER of 10%). Moderate to large effects 
were also observed on the composite estimates of PTSD and CPTSD DSO symptoms (low to 
high quality evidence), with NNTs of between 3 (PTSD + 1, 2, or 3 CPTSD DSO outcomes 
assuming CER of 50%) and 8 (PTSD + 3 CPTSD DSO outcomes assuming CER of 10%). 
However few studies measured more than one type of CPTSD DSO symptom. Significant 
publication bias was detected whenever there were sufficient studies to assess this, however 
only the estimate for disturbances in relationships was reduced when trim-and-fill analysis was 
applied. Compared to non-specific control interventions, CBT had a small effect on 
disturbances in relationships (k=3, g = -0.32; 95% CI = -0.60, -0.03) and a small-moderate 
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effect on PTSD symptoms (k=9, g = -0.37; 95% CI = -0.66, -0.09) (moderate quality evidence), 
with NNTs varying between 7 (PTSD assuming 50% CER) and 15 (disturbances in 
relationships assuming 10% CER). Although there was no evidence it had significant effects 
on affect dysregulation and negative self-concept, few studies reported usable data. When we 
pooled effects from all 9 studies reporting data on PTSD and at least one CPTSD DSO domain, 
a small effect was observed (k=9, g = -0.34; 95% CI = -0.62, -0.06; low quality evidence), with 
NNTs of between 8 (50% CER) and 14 (10% CER), but no studies measured more than one 
domain.  
 
Exposure therapy alone (Table 2, and supplement) 
As shown in Table 2, compared to usual care, exposure therapy alone had a moderate 
effect on disturbances in relationships (k=4, g = -0.59; 95% CI = -1.12, -0.07; moderate quality 
evidence), a moderate-large effect on negative self-concept (k=3, g = -0.73; 95% CI = -1.03, -
0.43; moderate quality evidence), and a large effect on PTSD symptoms (k=6, g = -1.05; 95% 
CI = -1.52, -0.58; low quality evidence), with NNTs of between 3 (PTSD - all assumed CERs) 
and 7 (disturbances in relationships, assuming 10% CER). No studies examined whether 
exposure was superior to usual care in relation to affect dysregulation. Moderate to large effects 
on the composite outcomes of PTSD and CPTSD DSO symptoms were observed (low to high 
quality evidence), with NNTs ranging from 3 (PTSD + 1, 2 or 3 CPTSD DSO outcomes, CERs 
of 22% and 50%) to 7 (PTSD + 2 or 3 CPTSD DSO outcomes, assuming 10% CER), however 
only one study provided usable data on more than one type of CPTSD DSO symptom. There 
was no evidence that exposure alone was superior to non-specific therapies in relation to 
disturbances in relationships, but only one study provided usable data. No studies reported 
whether exposure alone was superior to non-specific therapies in relation to either affect 
dysregulation or negative self-concept. Two studies found no effect of exposure alone on either 
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PTSD data, or the composite outcome of PTSD plus CPTSD DSO symptoms (low quality 
evidence). No studies provided data on more than one CPTSD DSO symptom.  
 
Eye-Movement and Desensitisation and Reprocessing therapy (EMDR) (Table 3, and 
supplement) 
As shown in Table 3, compared to usual care, the few available studies suggested 
EMDR had a moderate effect on negative self-concept (k=1, g = -0.61; 95% CI = -1.04, -0.17; 
low quality evidence), a moderate-large effect on disturbances in relationships (k=4, g = -0.76; 
95% CI = -1.35, -0.16; moderate quality evidence), and large effects on  affect dysregulation 
(k=1, g = -1.64; 95% CI = -2.56, -0.72; very low quality evidence) and PTSD symptoms (k=4, 
g = -1.26; 95% CI = -2.01, -0.51; low quality evidence), with NNTs ranging from 2 (affect 
dysregulation, all CERs) to 7 (disturbances in relationships, assuming CER of 10%). EMDR 
also had a large effect on the composite outcome of PTSD and at least one CPTSD DSO 
symptom (k=4, g = -1.15; 95% CI = -1.92, -0.37; low quality evidence), with NNTs of 2 (CER 
of 22%) or 3 (CER of 10% or 50%), but it did not have an effect on the composite outcome of 
PTSD and more than one CPTSD DSO symptom (very low quality evidence). There was no 
evidence that EMDR was superior to non-specific interventions in relation to disturbances in 
relationships or affect dysregulation (very low quality evidence). Although moderate-large 
effects on negative self-concept (k=2, g = -0.78; 95% CI = -1.56, -0.01) and PTSD symptoms 
(k=3, g = -0.69; 95% CI = -1.35, -0.03) (very low quality evidence) were observed, with NNTs 
of between 4 (negative self-concept, all CERs) and 6 (PTSD; CER of 10%), these analyses 
were based on only 2-3 studies. A moderate effect on the composite outcome of PTSD and at 
least one CPTSD DSO symptom was observed (k=3, g = -0.52; 95% CI = -0.97, -0.08; low 
quality evidence), with NNTs of between 5 (CER 50%) and 8 (CER 10%), but no effect was 
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found on the composite outcome of PTSD and more than one CPTSD DSO symptom (very 
low quality evidence). 
 
Comparison of CBT, Exposure and EMDR (Table 4, and supplement) 
As shown in Table 4, there was very limited evidence that EMDR had a small-moderate 
advantage over CBT in relation to PTSD symptoms (k=2, g = 0.37; 95% CI = 0.03, 0.71; low 
quality evidence), with an NNT of 7-12, but no differences between CBT, exposure alone or 
EMDR were observed for any other outcomes 
 
Other comparisons (supplement) 
As shown in Table J.1 (supplement), one small study (Krupnick 2008) found IPT had 
an advantage over usual care in reducing PTSD plus disturbances in relationships (k=1, g = -
1.02; 95% CI = -1.65, -0.39; very low quality evidence), with an NNT of  3-4, and another 
small study (Azad marzabadi 2014) found mindfulness was more effective than usual care in 
relation to disturbances in relationships (k=1, g = -1.60; 95% CI = -2.43, -0.77; very low quality 
evidence), with an NNT of 2-3. Several other small studies compared various 
psychotherapeutic interventions to other interventions, or to CBT, exposure or EMDR. We 
found no evidence to favour any particular intervention in relation to the composite outcome 
of PTSD plus CPTSD DSO symptoms (very low to low quality evidence). 
 
Moderator analyses (Figure 3, and supplement) 
As shown in Table L.1 (supplement), use of a non-specific control condition rather than 
usual care or waiting list was associated with a smaller benefit of psychological therapy in 
univariate meta-regression, with a reduction in Hedges’ g of 0.48, (95% CI = 0.18, 0.77). No 
other moderators were significant when examined individually. As shown in Table M.1 
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(supplement), the effect of using a non-specific control condition was larger in multivariate 
meta-regression, with a reduction in Hedges’ g of 0.69 (95% CI = 0.39, 1.00) in this analysis. 
Study quality and age of trauma onset also emerged as significant moderators of therapy effects 
in this analysis. Low quality studies were associated with a significantly lower effect size, with 
a reduction in Hedges’ g of 0.30 (95% CI = 0.00, 0.61). Studies where participants had 
predominantly childhood-onset trauma were associated with a reduction in Hedges’ g of 0.35 
(95% CI = 0.02, 0.69), when compared to trials where most participants had adult-onset trauma 
(Figure 3).  
 
Discussion 
We examined evidence from RCTs of psychological treatments for PTSD where 
participants were also likely to have clinically significant levels of one or more CPTSD DSO 
symptoms at baseline, and where usable data on the effect of interventions on these symptoms 
were reported. A total of 51 studies met inclusion criteria. Overall, results indicate that when 
compared to usual care, CBT, Exposure alone and EMDR perform relatively equally for 
symptoms of PTSD and the DSO symptoms of negative self-concept and disturbances in 
relationships. While the quality of this evidence was moderate for CBT, it ranged from low to 
moderate for Exposure alone and EMDR. Few trials reported the effectiveness of psychological 
therapies for symptoms of affect dysregulation. Low quality evidence suggests that EMDR has 
a small-moderate advantage over CBT in relation to PTSD symptoms, but there was no 
evidence of any differences between CBT, Exposure alone or EMDR for the other outcomes 
including DSO symptoms. Univariate and multivariate meta-regression confirmed that the 
effectiveness of psychological therapies was considerably lower when compared to non-
specific therapies, which suggests that non-specific effects may account for a large proportion 
of therapeutic change in symptoms of CPTSD in these trials. The multivariate meta-regression 
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also found that treatment outcome may be moderated by the developmental time of the onset 
of psychological trauma, with childhood trauma being associated with smaller effects of 
psychological therapies on CPTSD symptoms.  
The data are encouraging in that the accumulation of evidence suggests that there are 
specific interventions that work for several of the CPTSD symptom clusters. The data also 
suggest that no particular type of intervention (exposure, cognitive re-appraisal, bilateral 
stimulation) is necessary to resolve any one symptom cluster. A critical question is whether 
current treatments devised for PTSD are equally effective for those who will be diagnosed with 
CPTSD. Our results replicate earlier findings that individual trauma-focused treatments show 
large effect sizes. Although the evidence is at a very early stage, we found that some non-
trauma-focused therapies, such as mindfulness and IPT, may also reduce PTSD and 
interpersonal disturbance, suggesting alternative options. Importantly, childhood abuse was 
found to moderate all outcomes across all types of treatments, suggesting those with a history 
of childhood trauma may experience less improvement, and that current treatments for this 
patient population can be improved. These results have implications for the treatment of 
CPTSD as those with childhood abuse are at risk for CPTSD and in this meta-analysis may 
represent those more likely to have the full symptom profile.  
Research is needed to determine how to optimize treatment outcomes for those with 
childhood abuse and other populations at risk for CPTSD. This includes identifying which 
treatment interventions are most effective for specific symptom clusters, which are most 
acceptable to patients, in what order to present interventions and the optimal duration of 
different types of interventions. Considering current debates in the literature, it would have 
been useful to explore the usefulness of phased vs. non-phased interventions and individual vs. 
group interventions for CPTSD. Unfortunately, we did not find adequate evidence to enable 
further analysis of these treatment outcome moderators. There is substantial evidence 
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indicating that CPTSD and PTSD represent distinct patient populations with different 
symptoms profiles (Brewin et al., 2017), suggesting the value of developing treatments that 
more precisely and effectively resolve the differing effects of trauma exposure by 
systematically testing type, order and duration of interventions specific to each disorder and 
taking into account patient preferences across both disorders (Cloitre, 2015).  
Our meta-analysis has a number of strengths. We minimised the risk of bias by pre-
registering the review, and we minimised errors and omissions by having two or more 
reviewers conduct comprehensive searches, assess study quality and extract descriptive data. 
We considered a range of treatments from different countries and included participants with a 
range of backgrounds and types of psychological trauma including military, civilian and 
childhood trauma. Many studies have used qualified therapists and considered assessments of 
adherence to the protocol. However, most of the research was conducted in western countries, 
thus limiting the extent to which the findings may generalise to non-western countries. 
Furthermore, the evidence we have reviewed as part of this meta-analysis was predominantly 
on DSM-IV PTSD. Most studies did not present data on multiple traumatisation which 
typically results in CPTSD (Karatzias et al., 2016). Even when the index trauma that was 
targeted occurred in adulthood in included studies, it would be useful to assess lifetime 
traumatic history and consider the accumulative effect of multiple traumatisation. In relation 
to outcomes, we have only considered therapeutic gains at post-treatment. Future research 
should explore long-term outcomes of these interventions. Furthermore, for this meta-analysis 
we have used proxy measures for the CPTSD constructs. It might well be the case that a number 
of studies that included people with CPTSD have not been included in the study as they have 
not reported outcomes on relevant constructs or reported outcomes have not met clinical 
thresholds or our definition of ‘clinical significance’. It might also be the case that the measures 
employed in included studies do not accurately reflect the corresponding DSO clusters, thus 
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introducing some measurement bias. Moreover, while the quality of the meta-analytical 
evidence was high or moderate for some of the outcomes (e.g., when CBT was compared with 
usual care or non-specific control interventions), it was low or very low for most of the 
outcomes. Related to this, there was substantial heterogeneity for just over half of the outcomes. 
Thus, there is some uncertainty in the conclusions that can be drawn. It is also worth noting 
that we did not downgrade the meta-analytical outcomes for indirectness, as indirect evidence 
of psychological interventions for CPTSD was the focus of this review. If, on the other hand, 
we had been interested in direct evidence of psychological interventions for CPTSD, most if 
not all the outcomes would have been downgraded for indirectness.  
There is clearly a need for further well-designed trials of psychological therapies that 
incorporate appropriate methods of randomisation, blinding of assessors, long-term follow up 
and appropriate training of therapists and monitoring of treatment adherence. We have 
identified a set of research priorities to benefit people with CPTSD in the future that might 
directly or indirectly result from the findings of this review: 
• Effectiveness of phased vs. non-phased interventions for CPTSD: Very few included 
studies in this meta-analysis have incorporated a phased approach to treatment and it 
was not possible to address this question. 
• Effectiveness of trauma focused treatments vs. non – trauma focused treatments. 
Existing evidence is predominantly focused on trauma-focused treatments.  
• Head-to-head comparisons between trauma focused treatments for CPTSD. Most 
studies explored the effectiveness of interventions against standard care or no treatment.  
• Exploring safety of trauma focused therapies for CPTSD. It is essential that future 
research in this area provides information on adverse effects.  
• Investigation of whether diagnosis of CPTSD moderates outcomes when compared 
against those who do not meet diagnosis in standard treatments. Clinical reality suggests 
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that many people do not meet full diagnostic criteria but still suffer from a number of 
debilitating symptoms that relate to that condition. 
• Appropriateness and effectiveness of trauma focused treatments for CPTSD following 
childhood trauma. In this meta-analysis, childhood trauma was found to negatively 
moderate the effect of trauma focused interventions.  
• Comparing pharmacotherapy vs. psychotherapy for CPTSD. In this meta-analysis we 
did not address the effectiveness of pharmacotherapies alone or in combination with 
psychotherapy. 
• Considering the nature of the three DSO factors, it is worth exploring the effectiveness 
of attachment based interventions and relational therapies as limited evidence is 
currently present for these interventions. 
• Exploring the effectiveness of individual vs. group interventions for CPTSD. We found 
no evidence addressing this question for people with CPTSD. 
• Exploring the effectiveness of interventions that tackle all CPTSD symptom clusters in 
a single study using as a primary outcome of CPTSD based on a dedicated measure. 
The present review extracted proxy data from existing trials that measure the CPTSD 
constructs. 
In conclusion, this meta-analysis is the first step in identifying effective treatments for 
CPTSD. Findings regarding the usefulness of trauma-focused interventions look promising 
but less so for CPTSD symptoms following childhood trauma. Further research is needed to 
explore and develop existing and new treatments for CPTSD.  
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